While the mechanism(s) at the basis of these effects are unknown, but likely involving the immunomodulatory activities of Tα1, this study further encourages the use of Tα1, in combination with chemotherapy, in the treatment of metastatic melanoma. Here, TAAR1 is linked to metastatic melanoma.